Universal Solution or Therapeutic Overreach? Should LAAO Be the Default Approach for Stroke Prevention in All Atrial Fibrillation Patients?
Presenter
Karim Al-Azizi, M.D., FSCAI, Baylor Scott & White The Heart Hospital - Plano, Plano, TX
Karim Al-Azizi, M.D., FSCAI, Baylor Scott & White The Heart Hospital - Plano, Plano, TX
Learning Objectives:
- Discuss whether or not LAAO is as effective as anticoagulation
- Review SCAI guideline document on LAAO
- Speculations on Champion trial /catalyst trial